$XXX,XXX INVESTED SO FAR
Innovega Brings a Bold New Vision to a $572B Market
Smart glasses designed for the real world. Backed by patents, supported by early-stage trials, and powered by breakthrough tech.
Innovega is pioneering a new class of smart glasses that restore real-world vision for visually impaired and legally blind patients. We believe it’s the future of functional vision: no surgery, no bulky headsets. Just lightweight, fashionable glasses that help wearers read, recognize friends, and navigate their world with confidence. This scalable and connected platform is designed to leverage the power of AI and intelligent agents, setting the stage for advances in human capability.
Invest Now
This Reg CF offering is made available through StartEngine Primary, LLC, a member of FINRA/SPIC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

Innovega’s smart glasses are under development. Its contact lenses are investigational and not yet approved by the FDA. Results may vary.
introducing Next-Gen Smart Glasses. Stay Up To Date.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
By clicking "Stay Updated", you consent to receive marketing text messages (e.g. promos, cart reminders) from StartEngine Crowdfunding, Inc. at the number provided, including messages sent by autodialer. Consent is not a condition of purchase. Msg & data rates may apply. Msg frequency varies. Unsubscribe at any time by replying STOP or clicking the unsubscribe link (where available). Privacy Policy & Terms
75 Patents, 2,800+ Investors, $20M+ Raised
One Company, Two

Vision-Changing Products
Innovega is producing two revolutionary wearable vision systems designed to meet the diverse needs of individuals with moderate to severe visual impairment.
GEN I Smart Glasses
The GEN I Smart Glasses, set to launch in 2026, are lightweight, all-day wearable glasses equipped with high-resolution color cameras and customizable displays that enhance how users see their surroundings. These glasses allow real-time zoom, and they’re designed for AI and intelligent assistant compatibility. The Smart Glasses offer a discreet, stylish alternative to outdated tools like magnifiers or VR headsets.


Statements regarding product features, availability, and market alternatives are forward-looking and based on current development plans. Actual performance and commercialization timelines may differ. Product is under development. Final design may vary.
Gen II Smart Glasses + Contact Lenses
This system combines high-performance smart glasses with FDA-regulated nanotech contact lenses, delivering unprecedented functionality through a full field of view experience. The contacts let wearers simultaneously focus on things nearby and far away while the glasses project sharp digital images directly into the user’s field of vision.

‍
Product is under development. Final design may vary.
  *These testimonials reflect individual experiences with early-stage prototypes. Innovega’s contact lenses are investigational and not FDA-approved.
   The eyewear system is in development and not yet available. Results may vary.
Why Invest Now?
Restoring Vision Without Surgery or Headsets
Millions live with low vision, which can mean struggling to read, move safely, or recognize loved ones. Innovega’s smart glasses offer real-world clarity. In independent testing at The Ohio State University's College of Optometry, low vision participants (including individuals who are legally blind) achieved on average 20/20 visual acuity using Innovega's eyewear. 

Results are based on early-stage clinical testing and may vary by individual. Innovega’s contact lenses are investigational and not yet approved by the FDA.
Developing Breakthrough Vision Technology
Innovega's first generation of smart glasses, set to launch in 2026, will offer immediate and substantial improvement in vision, quality of life, and independence to 295M patients who struggle with vision loss, including those with AMD, Diabetic Retinopathy, Glaucoma, Ocular Albinism, Stargardt Disease, Juvenile Macular Degeneration, and other inherited conditions. Our planned Gen II system (as featured on the Discovery Channel) will pair smart glasses with FDA-regulated nanotech contact lenses and offer users even greater capabilities.
The features and benefits described are based on current product development goals and early-stage clinical testing. The contact lenses are investigational and not yet approved by the FDA. Actual results may vary, and no guarantees of patient outcomes can be made.
This video features early-stage development and investigational devices that are not FDA-approved. Product claims reflect current development goals and may change. Results may vary. No guarantees of future outcomes are made.
 *These testimonials reflect individual experiences with a product still in development. Results may vary.
Validated and Scaling
With manufacturing partners secured, FDA Phase I & II trials conducted, and a global market strategy in place, Innovega believes it is poised to scale.  Our tech has been tested by patients across the spectrum of vision diseases, our IP protected, and our early traction is real. As we prepare for commercialization, we’re inviting investors to join us at the inflection point.
Just the Beginning
Serving low vision patients is just the beginning. Innovega’s smart glasses platform is built to integrate cloud agents and intelligent assistants, delivering benefits to those with normal vision who want to experience media and life in a new way.
Invest in the Future of Sight
Smart Glasses Solutions for Low Vision Patients
Innovega’s eyewear system is a compact, wearable solution combining:
All of this is contained in a set of glasses that users actually want to wear.
A Market at $572B and Growing
  • The low vision and legally blind population is projected to grow as global lifespans increase
  • Assistive technology for vision impairment is part of the $572B+ global medical device market
  • Demand for non-invasive, AI-compatible wearable tech is growing, and Innovega sits at the intersection of both needs
The features and benefits described are based on current product development goals and early-stage clinical testing. The contact lenses are investigational and not yet approved by the FDA. Actual results may vary, and no guarantees of patient outcomes can be made. Market forecasts are forward-looking and based on third-party sources. Actual market conditions may differ.
Empowered by Visionaries
Stephen Willey is a co-founder of Innovega Inc. and accepted the role of Director in 2008, and CEO in 2011. Since 2011, his duties have included the company’s financing, administration, marketing, and business development. After earning graduate degrees in engineering and business, Mr. Willey led founding teams in 5 companies and successfully delivered innovation to global customers. In 1994, he co-founded and served as president of Microvision International Inc. Both the company and its subsidiary, Lumera, were listed on the NASDAQ exchange. He served as founding board member of Toronto Stock Exchange company, eDispatch, and CEO of TSX Venture Exchange company and telematics pioneer, AirIQ. Furthermore, he participated significantly in companies that launched innovations in cellular technology and video gaming, with eventual sale of these companies to global OEMs such as Motorola. Mr. Willey received an MBA degree from the University of California, in Los Angeles, and a Master of Science (Engineering) degree from The University of British Columbia.
Arthur led Systems Architecture in Apple's Vision Product Group and successfully shipped their ground-breaking Apple Vision Pro. Experience in growing and leading teams within organizations ranging from startups to global corporations. Adept at communicating across all levels and fostering collaboration between teams. Driven by curiosity to continually learn and innovate, with over 40 international patents. Arthur earned a Ph.D from UC San Diego, and this year will complete the CTO program offered by the Wharton Executive Education institute.
With over 25 years of experience in engineering and product design, Jay has a passion for developing innovative and cutting-edge solutions for near to eye display systems. Jay leads a team advancing complex display systems for immersive and augmented reality solutions to support patients with vision impairment.
Nick Brown is an accomplished Chief Financial Officer with over 25 years of experience leading financial operations, strategic planning, and risk management in several industries. Known for a strong track record of driving growth, optimizing financial performance, and fostering sustainable business success, Nick, combines deep expertise in financial forecasting, corporate governance, and cross-functional leadership. Throughout his career, Nick has played a pivotal role in guiding financial strategy at several companies, overseeing budgeting, financial reporting, mergers and acquisitions, and ensuring compliance with industry regulations. He is committed to delivering actionable insights to executives and stakeholders, aligning financial objectives with company goals to enhance profitability and operational efficiency. Before his current role, Nick served as CFO at SynergEyes Inc, where he helped lead the initiative that resulted in the SynergEyes and CooperVision merger. With a Bachelor of Science in Accounting from Indiana University, Nick brings both technical proficiency and leadership acumen to every facet of the organization.
Finance executive for over 30 years with progressive experience working for global entities like Microsoft and Cray and most recently as Global CFO of AGC Biologics. Currently working as advisor to several emerging growth tech, med tech, and healthcare ventures.
Join the
Vision Revolution
With real traction, transformative technology, and a proven team, Innovega believes it is offering investors an early-stage opportunity with potential impact and upside.
Invest Today
Learn How Innovega is Restoring Vision and Independence
By clicking "Learn more", you consent to receive marketing text messages (e.g. promos, cart reminders) from StartEngine Crowdfunding, Inc. at the number provided, including messages sent by autodialer. Consent is not a condition of purchase. Msg & data rates may apply. Msg frequency varies. Unsubscribe at any time by replying STOP or clicking the unsubscribe link (where available). Privacy Policy & Terms
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Innovega Terms
Overview
Price Per Share
$3.00
Valuation
$67.85M
Deadline1
Oct. 27, 2025 at 2:59 AM EDT
Funding Goal2
$10K - $5M
Breakdown
Min Investment
$498.00
Offering Type
Equity
Max Investment
$4,999,998.00
Shares Offered
Common Stock
Min Number of Shares Offered
3,333
Max Number of Shares Offered
1,666,666
*Maximum number of shares offered subject to adjustment for bonus shares. See Bonus info below.
Exclusive Investor Perks
Venture Club
Venture Club Members 
earn 10% bonus shares on top of this and all eligible investments for an entire year. Not a member? Sign up at checkout ($275/year).
Loyalty Bonus: 10% bonus shares for previous investors and select loyal supporters.

*In order to receive perks from an investment, one must submit a single investment in the same offering that meets the minimum perk requirement. Bonus shares from perks will not be granted if an investor submits multiple investments that, when combined, meet the perk requirement. All perks occur when the offering is completed.

Crowdfunding investments made through a self-directed IRA cannot receive non-bonus share perks due to tax laws. The Internal Revenue Service (IRS) prohibits self-dealing transactions in which the investor receives an immediate, personal financial gain on investments owned by their retirement account. As a result, an investor must refuse those non-bonus share perks because they would be receiving a benefit from their IRA account.

The 10% StartEngine Venture Club Bonus

Innovega Inc. will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Venture Club.

This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Common Stock at $3.00 / share, you will receive 110 shares of Common Stock, meaning you'll own 110 shares for $300. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% Bonus is only valid during the investor's eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.

Investors will receive the highest single bonus they are eligible for among the bonuses based on the amount invested and the time of offering elapsed (if any). Eligible investors will also receive the Venture Club Bonus, and the Loyalty Bonus in addition to the aforementioned bonus.Multiple investments in an offering cannot be combined to qualify for a larger campaign perk.

Time-Based Perks
Early Bird 1
$1,000+
Invest $1,000+ within the first 2 weeks and receive 7% bonus shares
Invest
Early Bird 2
$5,000+
Invest $5,000+ within the first 2 weeks and receive 10% bonus shares
Invest
Early Bird 3
$10,000+
Invest $10,000+ within the first 2 weeks and receive 13% bonus shares
Invest
Early Bird 4
$20,000+
Invest $20,000+ within the first 2 weeks and receive 15% bonus shares
Invest
Early Bird 5
$30,000+
Invest $30,000+ within the first 2 weeks and receive 30% bonus shares
Invest
Early Bird 6
$50,000+
Invest $50,000+ within the first 2 weeks and receive 35% bonus shares
Invest
Amount-Based Perks
Tier 1
$1,000+
Invest $1,000+ and receive 5% bonus shares
Invest
Tier 2
$5,000+
Invest $5,000+ and receive 7% bonus shares
Invest
Tier 3
$10,000+
Invest $10,000+ and receive 10% bonus shares
Invest
Tier 4
$20,000+
Invest $20,000+ and receive 13% bonus shares
Invest
Tier 5
$30,000+
Invest $30,000+ and receive 20% bonus shares
Invest
Tier 6
$50,000+
Invest $50,000+ and receive 25% bonus shares
Invest
Venture Club
Venture Club Members 
earn 10% bonus shares on top of this and all eligible investments for an entire year. Not a member? Sign up at checkout ($275/year).
Early Bird 1
$1,000+
Invest $1,000+ within the first 2 weeks and receive 7% bonus shares
Invest
Early Bird 2
$5,000+
Invest $5,000+ within the first 2 weeks and receive 10% bonus shares
Invest
Early Bird 3
$10,000+
Invest $10,000+ within the first 2 weeks and receive 13% bonus shares
Invest
Early Bird 4
$20,000+
Invest $20,000+ within the first 2 weeks and receive 15% bonus shares
Invest
Early Bird 5
$30,000+
Invest $30,000+ within the first 2 weeks and receive 30% bonus shares
Invest
Early Bird 6
$50,000+
Invest $50,000+ within the first 2 weeks and receive 35% bonus shares
Invest
Tier 1
$1,000+
Invest $1,000+ and receive 5% bonus shares
Invest
Tier 2
$5,000+
Invest $5,000+ and receive 7% bonus shares
Invest
Tier 3
$10,000+
Invest $10,000+ and receive 10% bonus shares
Invest
Tier 4
$20,000+
Invest $20,000+ and receive 13% bonus shares
Invest
Tier 5
$30,000+
Invest $30,000+ and receive 20% bonus shares
Invest
Tier 6
$50,000+
Invest $50,000+ and receive 25% bonus shares
Invest
Loyalty Bonus: 10% bonus shares for previous investors and select loyal supporters.
‍
*In order to receive perks from an investment, one must submit a single investment in the same offering that meets the minimum perk requirement. Bonus shares from perks will not be granted if an investor submits multiple investments that, when combined, meet the perk requirement. All perks occur when the offering is completed.
The 10% StartEngine Venture Club Bonus

Innovega Inc. will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Venture Club.

This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Common Stock at $3.00 / share, you will receive 110 shares of Common Stock, meaning you'll own 110 shares for $300. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% Bonus is only valid during the investor's eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.

Investors will receive the highest single bonus they are eligible for among the bonuses based on the amount invested and the time of offering elapsed (if any). Eligible investors will also receive the Venture Club Bonus, and the Loyalty Bonus in addition to the aforementioned bonus.Multiple investments in an offering cannot be combined to qualify for a larger campaign perk.

Join the Discussion

Please check your email for the One Time Password. Didn't Receive an email? click Here
LEGAL DISCLAIMER
This Reg CF offering is made available through StartEngine Primary LLC, member FINRA/SIPC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
Invest
© 2025 Innovega® All Rights Reserved Privacy Policy | Terms & Conditions